meso-NDGA en es it fr

meso-NDGA Brand names, meso-NDGA Analogs

meso-NDGA Brand Names Mixture

  • No information avaliable

meso-NDGA Chemical_Formula


meso-NDGA RX_link

meso-NDGA fda sheet


meso-NDGA msds (material safety sheet)


meso-NDGA Synthesis Reference

No information avaliable

meso-NDGA Molecular Weight

342.472 g/mol

meso-NDGA Melting Point


meso-NDGA H2O Solubility

2 µg/mL (at 37°C for the acetate salt)

meso-NDGA State


meso-NDGA LogP


meso-NDGA Dosage Forms

Oral suspension containing 125 mg of megestrol acetate per mL; Tablet

meso-NDGA Indication

For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used to treat breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.

meso-NDGA Pharmacology

Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.

meso-NDGA Absorption

Variable, but well absorbed orally.

meso-NDGA side effects and Toxicity

No serious unexpected side effects have resulted from studies involving megestrol acetate oral suspension administered in dosages as high as 1200 mg/day.

meso-NDGA Patient Information

No information avaliable

meso-NDGA Organisms Affected

Humans and other mammals